Foundation Medicine (FMI) 24.05 $FMI Chi-Med and

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Foundation Medicine (FMI) 24.05 $FMI

Chi-Med and AstraZeneca Amend Co-development Agreement to Accelerate Savolitinib Global Development Program
BusinessWire - Mon Aug 01, 2:32AM CDT
Chi-Med and AstraZeneca today announced an amendment (the "Amendment" to the 2011 global licensing, co-development, and commercialisation agreement (the "2011 Agreement" regarding savolitinib. Based on data from multiple Phase I/II studies, savolitinib has shown early clinical benefit as a highly selective c-Met inhibitor in a number of cancers.
FMI: 24.05 (+0.68), HCM: 12.98 (-0.15)

athenahealth (ATHN) Q2 Earnings Miss Estimates, Stock Down
Zacks Equity Research - Zacks Investment Research - Mon Jul 25, 10:23AM CDT
Shares of athenahealth plunged 12.2% to close at $124.92 on Jul 22, following its second-quarter 2016 results.
FMI: 24.05 (+0.68), QSII: 12.24 (-0.04), OMCL: 38.66 (-0.02), ATHN: 128.24 (+0.45)

Medidata's Payment Solution to Make Reimbursements Easy
Zacks Equity Research - Zacks Investment Research - Tue Jul 19, 6:03AM CDT
Medidata Solutions Inc. recently introduced Medidata Payments, a cloud-based payment technology.
FMI: 24.05 (+0.68), MDSO: 53.33 (+0.18), NVTA: 8.47 (-0.30), OMCL: 38.66 (-0.02)

Evolent Health Hits New 52 Week High, Valence Buy the Key
Zacks Equity Research - Zacks Investment Research - Fri Jul 15, 2:51PM CDT
Shares of Evolent Health Inc (EVH) scaled a new 52-week high of $23.64 on Jul 14.
FMI: 24.05 (+0.68), EVH: 23.56 (+0.02), STRM: 1.51 (+0.05), OMCL: 38.66 (-0.02)

New Data from Foundation Medicine and Collaborators Supports Use of Comprehensive Genomic Profiling to Inform Therapeutic Choices in Advanced Breast Cancer
BusinessWire - Mon Jun 06, 1:00PM CDT
--Biomarkers of Immune Checkpoint Inhibitors Identify Opportunity for Clinical Response to Immunotherapies
FMI: 24.05 (+0.68)

Data From a Study Utilizing FoundationOne(R) Heme Indicates Age-Associated Genomic Profiles in Acute Myeloid Leukemia
BusinessWire - Mon Jun 06, 8:00AM CDT
--Data Presented by Foundation Medicine and Collaborators at the 2016 ASCO Annual Meeting Further Propels the Advancement of Precision Medicine in Pediatric Cancers
FMI: 24.05 (+0.68)

Foundation Medicine Presents New Data at ASCO 2016 Demonstrating that FoundationOne(R) May Help Predict Response to Cancer Immunotherapy Across a Variety of Advanced Cancers
BusinessWire - Sun Jun 05, 10:30AM CDT
Foundation Medicine, Inc. (NASDAQ:FMI) and it collaborators presented data showing that higher tumor mutational burden, as estimated by comprehensive genomic profiling with FoundationOne(R), successfully predicted a greater likelihood of response and longer response duration to cancer immunotherapies in patients with advanced bladder cancer and metastatic melanoma as well as several other tumor types. The results were presented in two oral sessions, and several poster discussions at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place in Chicago.
FMI: 24.05 (+0.68)

FoundationOne(R) Identifies Patients with Advanced Lung Cancer Likely to Respond or Develop Resistance to Certain RET Inhibitor Therapies
BusinessWire - Sat Jun 04, 8:00AM CDT
Foundation Medicine, Inc. (NASDAQ:FMI) today announced new critical genomics data at the American Society of Clinical Oncology (ASCO) Annual Meeting 2016 demonstrating the clinical significance of comprehensive genomic profiling (CGP) with FoundationOne(R) in identifying patients with advanced lung cancer most likely to respond to RET inhibitor targeted therapies and also to predict those patients likely to develop resistance to targeted therapy.
FMI: 24.05 (+0.68)

Foundation Medicine and AstraZeneca Enter Strategic Collaboration for Lynparza Companion Diagnostic Assay
BusinessWire - Sat Jun 04, 7:00AM CDT
Foundation Medicine, Inc. (NASDAQ:FMI) and AstraZeneca today announced that they have entered into a definitive agreement to develop a novel companion diagnostic assay for Lynparza (olaparib) to support its global development program. The companion diagnostic will enable physicians to identify those patients most likely to benefit from AstraZeneca's first-in-class poly ADP-ribose polymerase (PARP) inhibitor.
FMI: 24.05 (+0.68)

Foundation Medicine to Present at the Goldman Sachs Annual Healthcare Conference
BusinessWire - Wed Jun 01, 5:30AM CDT
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that members of the company's management team will present at the Goldman Sachs Annual Healthcare Conference on Wednesday, June 8, 2016, at 2:00 p.m. PT in Rancho Palos Verdes, California.
FMI: 24.05 (+0.68)

COTA Increases Cross-Industry Support With the Addition of Celgene, Foundation Medicine, Inc., HealthScape Advisors and Novartis as Strategic Investors
Marketwire Canada - Tue May 24, 8:01AM CDT
Leading Health Care Informatics Company Gains Mission Momentum Across Health Care Discovery, Development, Delivery and Payment Sectors
FMI: 24.05 (+0.68), NVS: 83.04 (-0.22), CELGZ: 1.13 (-0.03)

Foundation Medicine Announces Presentations at ASCO
BusinessWire - Wed May 18, 4:20PM CDT
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the company and its collaborators will have two oral presentations, six poster discussions and nineteen posters presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2016 taking place June 3-7 in Chicago.
FMI: 24.05 (+0.68)

Foundation Medicine Receives Patent Covering Fundamental Methods in Comprehensive Genomic Analysis in Cancer
BusinessWire - Tue May 17, 5:30AM CDT
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the U.S. Patent and Trademark Office has issued U.S. patent number 9,340,830, entitled, "Optimization of Multigene Analysis of Tumor Samples." The patent, which is assigned to Foundation Medicine, includes fundamental claims describing methods of analyzing a cancer patient's tissue or blood specimen to detect multiple classes of genomic alterations. The patent carries a term extending to 2032. The company is also pursuing patent applications covering aspects of its genomic analysis platform with the European Patent Office and in other jurisdictions outside the United States.
FMI: 24.05 (+0.68)

Foundation Medicine reports 1Q loss
Automated Insights - Tue May 03, 4:15PM CDT
CAMBRIDGE, Mass. (AP) _ Foundation Medicine Inc. (FMI) on Tuesday reported a loss of $17.3 million in its first quarter.
FMI: 24.05 (+0.68)

Foundation Medicine Announces 2016 First Quarter Results and Recent Highlights
BusinessWire - Tue May 03, 3:04PM CDT
Foundation Medicine, Inc. (NASDAQ:FMI) today reported financial and operating results for its first quarter ended March 31, 2016. Highlights for the quarter included:
FMI: 24.05 (+0.68)

Foundation Medicine Announces Commercial Launch of Liquid Biopsy Assay, FoundationACT(TM)
BusinessWire - Tue May 03, 3:02PM CDT
Foundation Medicine, Inc. (NASDAQ:FMI) today announced the launch of FoundationACT (Assay for Circulating Tumor DNA), an analytically validated and accurate blood-based circulating tumor DNA (ctDNA) assay that provides patients and oncologists with a new option for comprehensive genomic profiling when a tissue biopsy is not feasible or when tissue is not available. By analyzing circulating tumor DNA isolated from a patient's blood, FoundationACT can identify clinically relevant genomic alterations, and like Foundation Medicine's tissue-based genomic profiles, FoundationOne(R) and FoundationOne Heme(R), FoundationACT delivers this comprehensive molecular information in a concise report that matches the findings with potentially relevant targeted therapies and clinical trials.
FMI: 24.05 (+0.68)

Foundation Medicine and AstraZeneca Collaborate to Develop Companion Diagnostic Assays in Oncology
BusinessWire - Tue May 03, 3:00PM CDT
Foundation Medicine, Inc. (NASDAQ:FMI) today announced an agreement with AstraZeneca to develop companion diagnostic assays to facilitate personalized medicine in oncology by identifying patients most likely to benefit from medicines within AstraZeneca's oncology pipeline.
FMI: 24.05 (+0.68)

Foundation Medicine to Present at Upcoming Investor Conferences
BusinessWire - Thu Apr 28, 5:30AM CDT
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that members of the company's management team will present at the following upcoming investor conferences:
FMI: 24.05 (+0.68)

Foundation Medicine's Molecular Information Supports Discovery of Precision Therapeutics for Pediatric Cancers
BusinessWire - Mon Apr 18, 3:30PM CDT
Foundation Medicine, Inc. (NASDAQ:FMI) today presented new data from more than 1,200 pediatric tumors across 51 cancer subtypes that were analyzed using the company's comprehensive genomic profiling assays, FoundationOne(R) and FoundationOne(R) Heme. The dataset reveals novel and potentially targetable genomic alterations identified during pediatric cancer clinical care that offer the possibility for new research towards novel therapeutics. In a separate but related announcement at the White House Precision Medicine Initiative Summit in February, Foundation Medicine made this data set publically available for research to motivate and accelerate development of new therapies to fight pediatric cancer.
FMI: 24.05 (+0.68)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 385

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 67

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 33

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 77

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Daqo New Energy Faces Key Investor Meeting in December

Updated Category News Views 44

Spotlight on December's Agenda for Daqo Shareholders Who'd have thought we'd be looking at another year end with the same burning energy interests? Daqo New Energy Corp. (NYSE: DQ) is setting up for its annual general meeting (AGM) dated December 10, 2026. Mark your calendars, because these gatherings can be more than just straightforward affairs; sometimes they reveal...

Continue Reading
KuCoin Unveils $1.1M USDT Black Friday Bonanza

Updated Category News Views 0

KuCoin's Festive Fireworks: Black Friday Bonanza Sometimes the crypto world feels like a carnival, and KuCoin's latest act is the $1.1 million USDT prize pool, rolling out as part of its 'Tis The Season holiday campaign. A move that matches the glitz of Tomorrowland Winter experiences, adding more sparkle to the crypto stage. Behind the Scenes of the KuCoin-Tomorrowland...

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 25

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading
Net Zero Efforts to Cost Europe €60B Annually by 2050

Updated Category News Views 38

Hefty Prices Loom Over Net Zero Commitments Well, strap in for a wallet buster, folks. Europe's largest players are staring down the barrel of a colossal €60 billion annual bill to clean up their carbon mess by 2050. That's the ticker in Senken's latest report, 'Pace of Change 2026.' Talks like these remind me there's no such thing as a free lunch, especially when...

Continue Reading
Sivers Semiconductors: Strategy Behind 2027 AGM Plans

Updated Category News Views 113

Setting the Stage for a Crucial Year Ah, the dance of corporate governance—an arena where maneuvering is an art. Sivers Semiconductors AB, a name that's becoming synonymous with innovation in the photonics and wireless solutions sector, is prepping for its 2027 Annual General Meeting. Ahead of this pivotal event, they're forming a Nomination Committee to shape future...

Continue Reading

Top 5 Most Recently Viewed Articles

Cypherpunk Technologies Boosts Zcash Holdings Significantly Year-Over-Year

Updated Category News Views 108

Cypherpunk Technologies Expands Zcash Accumulation CAMBRIDGE, Mass. — Cypherpunk Technologies Inc. (Nasdaq: CYPH), a company deeply engaged in privacy technology, has recently accelerated its efforts to accumulate Zcash, significantly boosting its treasury holdings. This move reflects their strategic commitment to enhancing their corporate asset portfolio and addressing...

Continue Reading
Insights from Access LIVE: The Future of Beverage Leadership

Updated Category News Views 253

Insights from Access LIVE: The Future of Beverage Leadership Leaders from the nation's largest distributors convened to share their insights on innovation, growth, and the future of the beverage alcohol industry. The session, known as "Wholesaler Power Hour — Market Drivers: Wholesale Leaders Blazing a Path to Success," took place on the LIVE Stage at Access LIVE 2025,...

Continue Reading
Understanding Microsoft's Competitive Edge in the Software Sector

Updated Category News Views 211

Dynamic Insights into Microsoft and Its Competitors In the rapidly evolving business landscape, a thorough examination of companies is vital for investors and enthusiasts alike. This article delves into a detailed comparative analysis of Microsoft (NASDAQ: MSFT) relative to its main competitors within the software industry. By evaluating essential financial metrics,...

Continue Reading
The Transformative Financial Journey of Pan American Silver Stock

Updated Category News Views 154

The Impact of Long-Term Investment in Pan American Silver Investing in stocks is often seen as a journey, and Pan American Silver (NYSE: PAAS) stands as a shining example of how patience can yield extraordinary rewards over the years. Over the last decade, Pan American Silver has surpassed market performance, boasting an annualized return of 22.95%, which is significantly...

Continue Reading
Linc Housing Initiates Construction of 90 Affordable Units

Updated Category News Views 219

Linc Housing Begins Construction on New Affordable Homes In a promising development for families in need, Linc Housing has commenced the construction of three new affordable apartment communities. This initiative will create 90 new homes specifically designed for low-income individuals and families. The timing could not be more critical, as communities grapple with an...

Continue Reading